United States v. Chube II

538 F.3d 693, 2008 U.S. App. LEXIS 17421, 2008 WL 3562641
CourtCourt of Appeals for the Seventh Circuit
DecidedAugust 15, 2008
Docket18-1362
StatusPublished
Cited by27 cases

This text of 538 F.3d 693 (United States v. Chube II) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Chube II, 538 F.3d 693, 2008 U.S. App. LEXIS 17421, 2008 WL 3562641 (7th Cir. 2008).

Opinion

WOOD, Circuit Judge.

Responding to growing concerns about widespread abuse of OxyContin, a Schedule II narcotic opioid often prescribed to treat chronic pain, the federal Drug Enforcement Administration (“DEA”) in 2001 launched a public campaign called the “Ox-yContin Action Plan” to ferret out unlawful uses of the drug. Dr. David Demaret Chube II and his brother Dr. Charles Randall Chube (“Dr. David” and “Dr. Randy,” respectively, or, collectively, “the Doctors”) were two of the hundreds of physicians investigated by the DEA for possible illegitimate prescribing of the drug. On February 2, 2005, the Doctors were charged in a 33-count indictment with unlawful distribution of controlled substances, health care fraud, and conspiracy to commit each of those offenses. After a two-week jury trial, the jury acquitted Dr. Randy of 32 out of 33 charges, and acquitted Dr. David of 27 out of 33 charges, rejecting both the conspiracy charges and many distribution charges. It found Dr. Randy guilty of one count of unlawful distribution and Dr. David guilty of four *695 counts of unlawful distribution and two counts of defrauding a health benefit program.

After the sentencing hearing, at which relevant conduct findings played a critical role in enhancing each brother’s advisory Guidelines range, the district court sentenced Dr. Randy to five years’ imprisonment and Dr. David to 15 years. Both men appeal. We affirm their convictions, but we vacate both sentences and remand for resentencing.

I

The Doctors jointly owned a clinic, Great Lakes Family Health Center, which opened its doors in 1998 in Gary, Indiana; they opened a second office two years later in nearby Munster, Indiana. Prior to starting the Great Lakes clinic, the two had practiced medicine with their father in Gary. During the years that the Doctors operated their clinics, many patients came to them seeking relief from severe chronic pain. Like many practitioners, the Doctors treated some of these complaints with OxyContin, a drug that has received praise from pain-management organizations and specialists for its ability to alleviate debilitating pain. From 1995 to 2001, the drug’s maker, Purdue Pharma, openly (and, we now know, falsely) marketed OxyContin to physicians as a less-addictive alternative to other pain-relieving drugs. Because of an emerging realization that OxyContin was addictive and thus prone to abuse, the drug eventually attracted the DEA’s attention.

The DEA was led to the Doctors by one of their patients, William Perry Mitchell, who lived in Benton Harbor, Michigan, about 70 miles from the Great Lakes clinic in Gary. He was one of several patients from that area. Although the Doctors had several legitimate patients, the proof at trial showed that others had no real medical complaints and went to the Doctors’ clinic solely to obtain OxyContin. Mitchell was arrested on September 17, 2001, and charged in the U.S. District Court for the Western District of Michigan with knowingly and intentionally distributing Oxy-Contin pills. Mitchell and his girlfriend had obtained the pills in question using prescriptions written by either Dr. David or Dr. Randy. In exchange for a provision in his plea agreement offering a possible reduction in his sentence, Mitchell agreed to name his “suppliers,” to testify against them, and to bring more witnesses to the Government who would do the same. Mitchell fulfilled all parts of his bargain, as did the Government.

The parties’ briefs present starkly different portraits of the defendants and their conduct. (We note, however, that at this stage we must view the facts in the light most favorable to the jury’s verdict. See Jackson v. Virginia, 443 U.S. 307, 319, 99 S.Ct. 2781, 61 L.Ed.2d 560 (1979); United States v. Thompson, 523 F.3d 806, 809-10 (7th Cir.2008).) According to the Doctors, the evidence demonstrated that they believed, in good faith and with good reason, that their patients were seeking treatment for true medical complaints. The problem they face is that the jury did not have to accept their protestations. But the Doctors also raise a legal argument: their convictions, they argue, assess their actions by reference to the standard of care applicable in a civil malpractice suit, but the proper standard is the one found in the Controlled Substances Act (“CSA”), which authorizes the conviction of a registered practitioner only if the prescription was written without a legitimate medical purpose and outside the scope of professional practice. The Government urges us to conclude that the evidence supports a finding that the Doctors were not using their medical licenses to treat *696 patients with true complaints, but were acting as common drug dealers, earning substantial amounts of money by prescribing drugs to addicts whom they knew had no legitimate medical complaints and without conducting sufficient physical examinations, diagnostic tests, or other appropriate inquiries or procedures to determine that the prescriptions were warranted. The jury found, the Government continues, that this conduct violated the CSA and thus went beyond simple malpractice. In other words, it found that the Doctors were acting not as physicians, but as profiteering pill-pushers.

The jury drew careful lines in its verdict. It exonerated the Doctors on the great majority of the charges, but it did convict Dr. Randy on one count of unlawful distribution, and Dr. David on four counts of unlawful distribution and two counts of health care fraud. On appeal, the Doctors support their argument about the erroneous use of the malpractice standard with an attack on two of the Government’s expert witnesses, Dr. Theodore Parran and Dr. Robert Barkin. Their testimony allegedly conflated the civil and criminal standards of care and thus created a risk that the jury found liability not because it concluded that the Doctors’ acts of prescribing medications fell outside the scope of legitimate medical practice, but instead because it thought they had been careless. The Doctors also argue that the experts’ testimony should not have been admitted because each impermissibly testified to legal conclusions.

The Government’s case was not limited to these two experts. The jury also heard from 15 patients, 11 of whom testified that they were suffering from true medical problems when they consulted the Doctors; the other four confessed that they fabricated their complaints solely to obtain painkillers. All said that they reported severe pain to the Doctors. Those who fabricated their complaints said they did not tell the Doctors that they were lying or that they were addicted to the drugs, for doing so would have thwarted their efforts to obtain the pills. The battleground of the litigation, then, was whether the Doctors knew that no legitimate medical reason existed for prescribing painkillers to these patients.

At sentencing, the district court’s relevant conduct findings dramatically enhanced each defendant’s advisory Guidelines range. Before adding the relevant conduct, Dr. Randy was facing an advisory Guidelines range of 0 to 6 months’ imprisonment; because this fell within Zone A of the Guidelines grid, probation alone would have been permissible. Dr. David was looking at an advisory Guidelines range of 21 to 27 months in prison. Relying primarily on spreadsheets of alleged unlawful prescriptions compiled by the Government, which included any

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Earl Miller
Seventh Circuit, 2025
United States v. Robert Hofschulz
105 F.4th 923 (Seventh Circuit, 2024)
United States v. Lisa Hofschulz
Seventh Circuit, 2024
United States v. Khan
989 F.3d 806 (Tenth Circuit, 2021)
Tom Tuduj v. Steven Newbold
958 F.3d 576 (Seventh Circuit, 2020)
United States v. Julio Diaz
876 F.3d 1194 (Ninth Circuit, 2017)
United States v. Naeem Kohli
847 F.3d 483 (Seventh Circuit, 2017)
United States v. Clara Rodriguez-Iznaga
575 F. App'x 583 (Sixth Circuit, 2014)
United States v. Paul Volkman
736 F.3d 1013 (Sixth Circuit, 2013)
United States v. Ronnie Walters
541 F. App'x 719 (Eighth Circuit, 2013)
United States v. Zolot
968 F. Supp. 2d 411 (D. Massachusetts, 2013)
United States v. Pellmann
668 F.3d 918 (Seventh Circuit, 2012)
Gatzimos v. Garrett
431 F. App'x 497 (Seventh Circuit, 2011)
Aberdeen v. Holder
392 F. App'x 207 (Fourth Circuit, 2010)
United States v. Griffith
584 F.3d 1004 (Tenth Circuit, 2009)
United States v. Rosenberg
585 F.3d 355 (Seventh Circuit, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
538 F.3d 693, 2008 U.S. App. LEXIS 17421, 2008 WL 3562641, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-chube-ii-ca7-2008.